Refractory Kawasaki disease: Infliximab or methotrexate therapy?

被引：0
|
作者：
Jae Il Shin
Jae Seung Lee
Jae Young Choi
Dong Soo Kim
Meenakshi Girish
机构：
[1] Yonsei University College of Medicine,Department of Pediatrics
[2] Severance Children’s Hospital,Dept of Pediatrics
[3] NKPSIMS,undefined
来源：
The Indian Journal of Pediatrics | 2009年 / 76卷 / 11期
关键词：
Infliximab; Kawasaki Disease; Coronary Artery Aneurysm; Kawasaki Disease Patient; Tumor Necrosis Factor Alpha Inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1184 / 1184
相关论文
共 50 条
  • [21] Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy
    Raman, V
    Kim, J
    Sharkey, A
    Chatila, T
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (06) : 635 - 637
  • [22] Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexate
    Tanaka, Fumiko
    Kawakami, Atsushi
    Iwanaga, Nozomi
    Tamai, Mami
    Izumi, Yasumori
    Aratake, Kouichiro
    Arima, Kazuhiko
    Kamachi, Makoto
    Nakamura, Hideki
    Huang, Mingguo
    Ida, Hiroaki
    Origuchi, Tomoki
    Eguchi, Katsumi
    INTERNAL MEDICINE, 2006, 45 (05) : 313 - 316
  • [23] Psoriasiform eruption with arthritis post infliximab use in Kawasaki disease
    Mitsui, Kiyomaro
    Fukuhara, Daisuke
    Kimura, Toshihiko
    Ando, Rie
    Narita, Masami
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [24] Infliximab regulates monocytes and regulatory T cells in Kawasaki disease
    Koizumi, Keiichi
    Hoshiai, Minako
    Katsumata, Nobuyuki
    Toda, Takako
    Kise, Hiroaki
    Hasebe, Yohei
    Kono, Yosuke
    Sunaga, Yuto
    Yoshizawa, Masashi
    Watanabe, Atsushi
    Kagami, Keiko
    Abe, Masako
    Sugita, Kanji
    PEDIATRICS INTERNATIONAL, 2018, 60 (09) : 796 - 802
  • [25] Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Beh‡et's disease
    Iwata, Shigeru
    Saito, Kazuyoshi
    Yamaoka, Kunihiro
    Tsujimura, Shizuyo
    Nawata, Masao
    Hanami, Kentaro
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2011, 21 (02) : 184 - 191
  • [26] Infliximab as a second-line therapy for children with refractory Kawasaki disease: A systematic review and meta-analysis of randomized controlled trials
    Kabbaha, Suad
    Milano, Alyssa
    Aldeyab, Mamoon A.
    Thorlund, Kristian
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (01) : 49 - 60
  • [27] Recurrent refractory Kawasaki disease
    P Costa Reis
    S Nativ
    A Starr
    L Imundo
    A Eichenfield
    Pediatric Rheumatology, 9 (Suppl 1)
  • [28] Acute Kawasaki Disease Therapy
    Dionne A.
    Newburger J.W.
    Friedman K.G.
    Current Treatment Options in Pediatrics, 2019, 5 (3) : 293 - 300
  • [29] Adjunct cyclosporine therapy for refractory Kawasaki disease in a very young infant
    Okada, Seigo
    Azuma, Yoshihiro
    Suzuki, Yasuo
    Yamada, Hiroko
    Wakabayashi-Takahara, Midori
    Korenaga, Yuno
    Akase, Hideaki
    Hasegawa, Shunji
    Ohga, Shouichi
    PEDIATRICS INTERNATIONAL, 2016, 58 (04) : 295 - 298
  • [30] Infliximab in refractory coeliac disease
    Chaudhary, R
    Ghosh, S
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (06) : 603 - 604
12345